Serial Number | 97828587 |
Word Mark | CRISPRX |
Filing Date | Wednesday, March 8, 2023 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Monday, March 25, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Description of Mark | The mark consists of of the term CRISPRX with a line under the letters RISP. |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Goods and Services | Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, March 28, 2023 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | CRISPR Therapeutics AG |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | ZUG V8 6300 CH |
Event Date | Event Description |
Monday, March 25, 2024 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Monday, March 25, 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Tuesday, September 12, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, September 12, 2023 | NON-FINAL ACTION E-MAILED |
Tuesday, September 12, 2023 | NON-FINAL ACTION WRITTEN |
Tuesday, September 12, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, September 12, 2023 | NON-FINAL ACTION E-MAILED |
Tuesday, September 12, 2023 | NON-FINAL ACTION WRITTEN |
Friday, July 14, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, July 14, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, July 14, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Thursday, July 13, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
Thursday, July 13, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
Friday, April 14, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, April 14, 2023 | NON-FINAL ACTION E-MAILED |
Friday, April 14, 2023 | NON-FINAL ACTION WRITTEN |
Friday, March 31, 2023 | ASSIGNED TO EXAMINER |
Wednesday, March 29, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Tuesday, March 28, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Saturday, March 11, 2023 | NEW APPLICATION ENTERED |